Healthcare companies set out their stall at Shanghai expo

To meet the growing public demand for chronic disease management, London-based GlaxoSmithKline held a roundtable event in Shanghai. Experts from disease control and clinical fields discussed how to further integrate disease treatment and prevention efforts, and optimize strategies for the coordinated prevention and control of chronic and infectious diseases, ultimately reducing the infection burden on chronic disease patients and enhancing the resilience of the public health system.

Sun Xiaodong, deputy director of the Shanghai Center for Disease Control and Prevention, said, "In the future, we need to consider incorporating more high-risk factors, such as infectious diseases like shingles, into chronic disease prevention and treatment, promoting the integration of immunization and chronic disease management to help improve the overall efficiency of public health."

Elsewhere at this week's CIIE, Japan's maternal and infant care company Pigeon signed a new memorandum of understanding with the National Health Commission's National Center for Women and Children's Health to jointly promote scientific infant feeding and health enhancement.

Through past collaborations with the center, Pigeon has supported a breastfeeding consultation program that now covers 31 provincial-level regions, reaching 8,500 medical institutions and benefiting more than 5.5 million newborn families around China.

"The company will continue to work with various sectors of society to promote high-quality development in China's maternal and child field and contribute to building a birth-friendly society," said Zhou Jianfeng, president of Pigeon China.